Uploaded via media manager.

FDA approves first COVID treatment pill

This week, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) of the first antiviral pill to treat COVID-19 at home. Called Paxlovid, it is intended for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older).

Paxlovid is made by Pfizer. It's taken twice a day for five days in combination with a second medicine called ritonavir, a generic antiviral. It is the first treatment for COVID-19 that is in the form of a pill that is taken orally.

Who can use Paxlovid?

The current guidelines for use of Paxlovid are:

  • Adults and children who are 12 years of age and older weighing at least 88 pounds (40 kg)
  • With a confirmed COVID-19 infection
  • Within five days of symptoms onset
  • Who are at high risk for progression to severe COVID-19, including hospitalization or death, irrespective of vaccination status (for example: Immune-compromised, cancer, multiple advanced medical comorbidities, >60 years old)

Availability at ARC

As of now, we have been informed that it will take a few days to a couple of weeks before Paxlovid is shipped by the manufacturer and before it will become available for prescribing. ARC doctors will begin prescribing Paxlovid as soon as it becomes available in our community.

In the meantime…

Please continue taking all precautions against COVID-19, including vaccination and booster shot, masking when inside and when in crowded outdoor situations, hand hygiene, and social distancing.

If you need a COVID-19 vaccine or booster, they are available at ARC by appointment. Book a COVID vaccine or booster appointment online.

If you need a COVID-19 test, they are available at ARC by appointment. Book a COVID test online.

Current treatment. Monoclonal antibody treatment is currently available in the Austin area. If you are at elevated risk of severe COVID-19 and/or hospitalization, ask your physician about this treatment.

Still have questions? Visit our COVID-19 FAQ page for answers.


Tags: COVID-19, paxlovid

More on this Topic

What have we learned in two years of COVID-19?

Anas Daghestani, MD, ARC CEO, and Amy B. Siegel, MD, ARC Internal Medicine and ARC Clinical Researcher, share their thoughts and lessons from the last two years of the pandemic in this recent article.

Keeping you up to date on the COVID-19 kids vax

Elizabeth C. Knapp, MD, Pediatrics at ARC Far West, sat down to talk to Spectrum News about the latest news on the COVID-19 vaccine for kids ages 5-11 years old. Hear what she has to say about the efficacy and safety of this shot for children.

Protecting our youngest children from COVID-19

The only way we can protect our children is to make sure that everybody is wearing their mask, socially distancing, and vaccinated when possible. See what else Dr. Elizabeth Knapp has to say about protecting our vulnerable community members.

Back-to-school and COVID: bringing the risk home

A look at the COVID risk factors in households with school age children. Dr. Sunaina Suhag and Dr. David Gray talk about how back-to-school affects the entire household?

Back-to-school reassurance from pediatricians

James Anderson, IV, MD, Pediatrician at ARC Far West, prioritizes pediatric mental health. Learn why Dr. Anderson says the COVID impact isn’t just sickness.